|
1
|
Guibert M, Lepage B, Woisard V, Rives M,
Serrano E and Vergez S: Quality of life in patients treated for
advanced hypopharyngeal or laryngeal cancer. Eur Ann
Otorhinolaryngol Head Neck Dis. 128:218–223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuomi L, Andréll P and Finizia C: Effects
of voice rehabilitation after radiation therapy for laryngeal
cancer: A randomized controlled study. Int J Radiat Oncol Biol
Phys. 89:964–972. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robertson SM, Yeo JC, Sabey L, Young D and
MacKenzie K: Effects of tumor staging and treatment modality on
functional outcome and quality of life after treatment for
laryngeal cancer. Head Neck. 35:1759–1763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Möhner M, Lindtner M and Otten H: Ionizing
radiation and risk of laryngeal cancer among German uranium miners.
Health Phys. 95:725–733. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giotakis AI, Kontos CK, Manolopoulos LD,
Sismanis A, Konstadoulakis MM and Scorilas A: High BAX/BCL2 mRNA
ratio predicts favorable prognosis in laryngeal squamous cell
carcinoma, particularly in patients with negative lymph nodes at
the time of diagnosis. Clin Biochem. 49:890–896. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tae K, Jin BJ, Ji YB, Jeong JH, Cho SH and
Lee SH: The role of laryngopharyngeal reflux as a risk factor in
laryngeal cancer: A preliminary report. Clin Exp Otorhinolaryngol.
4:101–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Narwani V, Nalamada K, Lee M, Kothari P
and Lakhani R: Readability and quality assessment of internet-based
patient education materials related to laryngeal cancer. Head Neck.
38:601–605. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, Wang
BX and Dong P: Gene and microRNA expression reveals sensitivity to
paclitaxel in laryngeal cancer cell line. Int J Clin Exp Pathol.
6:1351–1361. 2013.PubMed/NCBI
|
|
9
|
Yu D, Jin C, Liu Y, Yang J, Zhao Y, Wang
H, Zhao X, Cheng J, Liu X and Liu C: Clinical implications of
cancer stem cell-like side population cells in human laryngeal
cancer. Tumour Biol. 34:3603–3610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei X, Wang J, He J, Ma B and Chen J:
Biological characteristics of CD133(+) cancer stem cells
derived from human laryngeal carcinoma cell line. Int J Clin Exp
Med. 7:2453–2462. 2014.PubMed/NCBI
|
|
11
|
Lust S, Vanhoecke B, VAN Gele M, Boelens
J, VAN Melckebeke H, Kaileh M, Berghe W Vanden, Haegeman G,
Philippé J, Bracke M and Offner F: Xanthohumol activates the
proapoptotic arm of the unfolded protein response in chronic
lymphocytic leukemia. Anticancer Res. 29:3797–3805. 2009.PubMed/NCBI
|
|
12
|
Monteghirfo S, Tosetti F, Ambrosini C,
Stigliani S, Pozzi S, Frassoni F, Fassina G, Soverini S, Albini A
and Ferrari N: Antileukemia effects of xanthohumol in
Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53
modulation. Mol Cancer Ther. 7:2692–2702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen PH, Chang CK, Shih CM, Cheng CH, Lin
CW, Lee CC, Liu AJ, Ho KH and Chen KC: The miR-204-3p-targeted
IGFBP2 pathway is involved in xanthohumol-induced glioma cell
apoptotic death. Neuropharmacology. 110:362–375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dokduang H, Yongvanit P, Namwat N,
Pairojkul C, Sangkhamanon S, Yageta MS, Murakami Y and Loilome W:
Xanthohumol inhibits STAT3 activation pathway leading to growth
suppression and apoptosis induction in human cholangiocarcinoma
cells. Oncol Rep. 35:2065–2072. 2016.PubMed/NCBI
|
|
15
|
Zajc I, Filipič M and Lah TT: Xanthohumol
induces different cytotoxicity and apoptotic pathways in malignant
and normal astrocytes. Phytother Res. 26:1709–1713. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Colgate EC, Miranda CL, Stevens JF, Bray
TM and Ho E: Xanthohumol, a prenylflavonoid derived from hops
induces apoptosis and inhibits NF-kappaB activation in prostate
epithelial cells. Cancer Lett. 246:201–209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yong WK and Abd Malek SN: Xanthohumol
induces growth inhibition and apoptosis in ca ski human cervical
cancer cells. Evid Based Complement Alternat Med. 2015:9213062015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wakisaka N, Kondo S, Endo K, Murono S and
Yoshizaki T: Adjuvant chemotherapy with an oral fluoropyrimidine,
S-1, following reduced RADPLAT in advanced laryngeal cancer. Ann
Otol Rhinol Laryngol. 121:555–562. 2012.PubMed/NCBI
|
|
19
|
Melinceanu L, Sarafoleanu C, Lerescu L,
Tucureanu C, Caras I and Sălăgeanu A: Impact of smoking on the
immunological profile of patients with laryngeal carcinoma. J Med
Life. 2:211–218. 2009.PubMed/NCBI
|
|
20
|
Wan G, Zhou L, Xie M, Chen H and Tian J:
Characterization of side population cells from laryngeal cancer
cell lines. Head Neck. 32:1302–1309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qu X, Xu C, Wang H, Xu J, Liu W, Wang Y,
Jia X, Xie Z, Xu Z, Ji C, et al: Hippocampal glutamate level and
glutamate aspartate transporter (GLAST) are up-regulated in senior
rat associated with isoflurane-induced spatial learning/memory
impairment. Neurochem Res. 38:59–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshimaru T, Komatsu M, Tashiro E, Imoto
M, Osada H, Miyoshi Y, Honda J, Sasa M and Katagiri T: Xanthohumol
suppresses oestrogen-signalling in breast cancer through the
inhibition of BIG3-PHB2 interactions. Sci Rep. 4:73552014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Li X, Zhang Y and Luan X:
Luteolin induces apoptosis by activating Fas signaling pathway at
the receptor level in laryngeal squamous cell line Hep-2 cells. Eur
Arch Otorhinolaryngol. 271:1653–1659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Corbiere C, Liagre B, Terro F and
Beneytout JL: Induction of antiproliferative effect by diosgenin
through activation of p53, release of apoptosis-inducing factor
(AIF) and modulation of caspase-3 activity in different human
cancer cells. Cell Res. 14:188–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Deng M, Ma L, Zhou J, Xiao Y, Zhou
X, Zhang C and Wu M: Inhibitory effects of forkhead box L1 gene on
osteosarcoma growth through the induction of cell cycle arrest and
apoptosis. Oncol Rep. 34:265–271. 2015.PubMed/NCBI
|
|
26
|
Akagi T, Shimizu K, Takahama S, Iwasaki T,
Sakamaki K, Endo Y and Sawasaki T: Caspase-8 cleavage of the
interleukin-21 (IL-21) receptor is a negative feedback regulator of
IL-21 signaling. FEBS Lett. 585:1835–1840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan L, Becker H and Gerhäuser C:
Xanthohumol induces apoptosis in cultured 40–16 human colon cancer
cells by activation of the death receptor- and mitochondrial
pathway. Mol Nutr Food Res. 49:837–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kunnimalaiyaan S, Sokolowski KM,
Balamurugan M, Gamblin TC and Kunnimalaiyaan M: Xanthohumol
inhibits Notch signaling and induces apoptosis in hepatocellular
carcinoma. PLoS One. 10:e01274642015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang N, Zhang JH, Qiu F, Tashiro S,
Onodera S and Ikejima T: Inhibition of EGFR signaling augments
oridonin-induced apoptosis in human laryngeal cancer cells via
enhancing oxidative stress coincident with activation of both the
intrinsic and extrinsic apoptotic pathways. Cancer Lett.
294:147–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kropveld A, Slootweg PJ, van Mansfeld AD,
Blankenstein MA and Hordijk GJ: Radioresistance and p53 status of
T2 laryngeal carcinoma. Analysis by immunohistochemistry and
denaturing gradient gel electrophoresis. Cancer. 78:991–997. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pei SG, Wang JX, Wang XL, Zhang QJ and
Zhang H: Correlation of survivin, p53 and Ki-67 in laryngeal cancer
Hep-2 cell proliferation and invasion. Asian Pac J Trop Med.
8:636–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Simsek H, Han U, Onal B and Simisek G: The
expression of EGFR, cerbB2, p16, and p53 and their relationship
with conventional parameters in squamous cell carcinoma of the
larynx. Turk J Med Sci. 44:411–416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ogawa T, Shiga K, Tateda M, Saijo S,
Suzuki T, Sasano H, Miyagi T and Kobayashi T: Protein expression of
p53 and Bcl-2 has a strong correlation with radiation resistance of
laryngeal squamous cell carcinoma but does not predict the
radiation failure before treatment. Oncol Rep. 10:1461–1466.
2003.PubMed/NCBI
|
|
34
|
Mendivil-Perez M, Velez-Pardo C and
Jimenez-Del-Rio M: TPEN induces apoptosis independently of zinc
chelator activity in a model of acute lymphoblastic leukemia and ex
vivo acute leukemia cells through oxidative stress and mitochondria
caspase-3- and AIF-dependent pathways. Oxid Med Cell Longev.
2012:3132752012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cho SY, Lee JH, Ju MK, Jeong EM, Kim HJ,
Lim J, Lee S, Cho NH, Park HH, Choi K, et al: Cystamine induces
AIF-mediated apoptosis through glutathione depletion. Biochim
Biophys Acta. 1853:619–631. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang R, Cui HJ, Wang H, Wang Y, Liu JH, Li
Y and Lu Y: N-stearoyltyrosine protects against glutamate-induced
oxidative toxicity by an apoptosis-inducing factor (AIF)-mediated
caspase-independent cell death pathway. J Pharmacol Sci.
124:169–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hunter TB, Manimala NJ, Luddy KA, Catlin T
and Antonia SJ: Paclitaxel and TRAIL synergize to kill
paclitaxel-resistant small cell lung cancer cells through a
caspase-independent mechanism mediated through AIF. Anticancer Res.
31:3193–3204. 2011.PubMed/NCBI
|
